Tryngolza is once-monthly, subcutaneous RNA-targeted therapy and is expected to be available by the end of the year with a ...

The new, now-defeated bill eliminated the PBM reform measures included in a larger spending bill that the president-elect and ...

A new study shows that nearly 90% of patients with moderate-to-severe atopic dermatitis (AD) reported their condition ...

Anna Podolanczuk, M.D., M.S., discusses how the mortality rates for patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) are impacted by comorbidities, including ...

The Institute for Clinical and Economic Review assessed the formularies of 11 payers, covering 57 million people, to ...

Menopausal gay, lesbian and bisexual women are more likely to report recent sexual activity with less vaginal symptoms than ...

The boxed warning follows a safety warning the FDA issued in September about the risk of liver injury from the use of Veozah ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Spending reached $4.86 trillion in 2023, a 7.5% increase from 2022 The growth in spending on hospital care was the highest since 1990.

Women are more than twice as likely to develop post-traumatic stress disorder than men, and a new study demonstrates for the ...

The FDA has approved Celltrion’s Stelara biosimilar Steqeyma (CT-P43), for adult and pediatric patients with plaque psoriasis ...

A new bill in Congress would require pass-through prices in both Medicare, and Medicaid and require transparency of PBM ...